Literature DB >> 10234427

Anger inhibition, cardiovascular recovery, and vagal function: a model of the link between hostility and cardiovascular disease.

J F Brosschot1, J F Thayer.   

Abstract

A model of the association between hostility and cardiovascular disease (CVD) is proposed based upon anger inhibition, slow cardiovascular recovery, and low parasympathetic activity (vagal tone). This model is opposed to the more conventional model that emphasizes anger expression, cardiovascular reactivity, and high sympathetic tone. We argue that in social reality, incidences of anger inhibition outnumber incidences of anger expression to a great extent, irrespective of preferred expression style. Moreover, slow cardiovascular recovery, rather than high reactivity, may be the mechanism underlying the CVD risk associated with anger inhibition. Both anger inhibition and slow cardiovascular recovery are associated with a persistently low vagal tone. Thus, the anger inhibition/vagal inhibition model seems more consistent with the actual nature of anger in daily life and with the known cardiovascular control mechanisms. The model may better account for the chronic pathophysiological state that is believed to lead to CVD. Importantly, an experimental inhibition/recovery paradigm might also allow to test potential behavioral and cognitive accelerators of cardiovascular recovery. As an example of an important socially-mediated health risk that may be elucidated using the anger inhibition/vagal inhibition model, we discuss Black-White differences that have been found in CVD.

Entities:  

Mesh:

Year:  1998        PMID: 10234427     DOI: 10.1007/BF02886382

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  44 in total

Review 1.  'Heart-talk:' considering the role of the heart in therapy as evidenced in the Quran and medical research.

Authors:  Feryad Hussain
Journal:  J Relig Health       Date:  2013-12

2.  Look on the bright side: do the benefits of optimism depend on the social nature of the stressor?

Authors:  Alexandra L Terrill; John M Ruiz; John P Garofalo
Journal:  J Behav Med       Date:  2010-06-20

Review 3.  Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence.

Authors:  Eric A Dedert; Patrick S Calhoun; Lana L Watkins; Andrew Sherwood; Jean C Beckham
Journal:  Ann Behav Med       Date:  2010-02

4.  Anger cognitions and cardiovascular recovery following provocation.

Authors:  Sonia Suchday; Michele M Carter; Craig K Ewart; Kevin T Larkin; Otello Desiderato
Journal:  J Behav Med       Date:  2004-08

5.  Positive emotions: exploring the other hemisphere in behavioral medicine.

Authors:  Margaret A Chesney; Lynae A Darbes; Kate Hoerster; Jonelle M Taylor; Donald B Chambers; David E Anderson
Journal:  Int J Behav Med       Date:  2005

6.  The influence of trait and state rumination on cardiovascular recovery from a negative emotional stressor.

Authors:  Brenda L Key; Tavis S Campbell; Simon L Bacon; William Gerin
Journal:  J Behav Med       Date:  2008-03-19

7.  On the importance of inhibition: central and peripheral manifestations of nonlinear inhibitory processes in neural systems.

Authors:  Julian F Thayer
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

8.  Marital conflict and children's externalizing behavior: interactions between parasympathetic and sympathetic nervous system activity.

Authors:  Mona El-Sheikh; Chrystyna D Kouros; Stephen Erath; E Mark Cummings; Peggy Keller; Lori Staton
Journal:  Monogr Soc Res Child Dev       Date:  2009

Review 9.  Anger inhibition and pain: conceptualizations, evidence and new directions.

Authors:  John W Burns; Phillip J Quartana; Stephen Bruehl
Journal:  J Behav Med       Date:  2008-05-23

10.  Cardiac vagal activity during psychological stress varies with social functioning in older women.

Authors:  Victoria B Egizio; J Richard Jennings; Israel C Christie; Lei K Sheu; Karen A Matthews; Peter J Gianaros
Journal:  Psychophysiology       Date:  2008-09-24       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.